| Online-Ressource |
Verfasst von: | Fellenberg, Jörg [VerfasserIn]  |
| Sähr, Heiner [VerfasserIn]  |
| Mancarella, D. [VerfasserIn]  |
| Plass, C. [VerfasserIn]  |
| Lindroth, A. M. [VerfasserIn]  |
| Westhauser, Fabian [VerfasserIn]  |
| Lehner, Burkhard [VerfasserIn]  |
| Ewerbeck, Volker [VerfasserIn]  |
Titel: | Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells |
Verf.angabe: | J. Fellenberg, H. Sähr, D. Mancarella, C. Plass, A.M. Lindroth, F. Westhauser, B. Lehner, V. Ewerbeck |
E-Jahr: | 2019 |
Jahr: | 8 February 2019 |
Umfang: | 9 S. |
Teil: | volume:448 |
| year:2019 |
| pages:61-69 |
| extent:9 |
Fussnoten: | Gesehen am 09.07.2019 |
Titel Quelle: | Enthalten in: Cancer letters |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1975 |
Jahr Quelle: | 2019 |
Band/Heft Quelle: | 448(2019), Seite 61-69 |
ISSN Quelle: | 1872-7980 |
Abstract: | Giant cell tumors of bone (GCTB) are semi-malignant tumors associated with extensive osteolytic defects and massive bone destructions. They display a locally aggressive behavior and a very high recurrence rate. Recently, a single mutation has been identified in GCTB affecting the H3F3A gene coding for the histone variant H3.3 (H3.3-G34W). The aim of this study was to investigate whether H3.3-G34W is sufficient to drive tumorigenesis in GCTB. Initially, we confirmed the high frequency of this mutation in 94% of 84 analyzed tissue samples. Using a siRNA based approach we could selectively knockdown H3.3-G34W in primary neoplastic stromal cells isolated from tumor tissue (GCTSC). H3.3-G34W knockdown caused a significant inhibition of cell proliferation, migration and colony formation capacity in vitro. Xenotransplantation of GCTSCs onto the chorioallantoic membrane of fertilized chicken eggs further demonstrated a significant impact of H3.3-G34W knockdown on tumor engraftment and growth in vivo. Our data indicate that H3.3-G34W is sufficient to drive tumorigenesis in GCTB. Apart from the application of H3.3-G34W screening as diagnostic tool, our data suggest that H3.3-G4W represents a promising target for the development of new GCTB therapies. |
DOI: | doi:10.1016/j.canlet.2019.02.001 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1016/j.canlet.2019.02.001 |
| Volltext: http://www.sciencedirect.com/science/article/pii/S0304383519300631 |
| DOI: https://doi.org/10.1016/j.canlet.2019.02.001 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | CAM assay |
| Giant cell tumor of bone |
| H3.3-G34W |
| Histone |
| Neoplastic transformation |
K10plus-PPN: | 1668836467 |
Verknüpfungen: | → Zeitschrift |
Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells / Fellenberg, Jörg [VerfasserIn]; 8 February 2019 (Online-Ressource)